Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Single pivotal trial can provide clinical evidence of drug efficacy, Sen. Jeffords tells DIA.

This article was originally published in The Tan Sheet

Executive Summary

SINGLE PIVOTAL TRIAL PROVIDES ADEQUATE DRUG APPROVAL BASIS, SEN. JEFFORDS told the plenary session of the Drug Information Association annual meeting in Boston June 8. "We expect that FDA will move away from the rote assumption that every product application must have two clinical trials," Sen. James Jeffords (R-Vt.) said. Instead, each application should be approached "with an open mind. The power of today's clinical trials and research technique can often provide the evidence needed in just one trial," he observed.
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088544

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel